vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and GSI TECHNOLOGY INC (GSIT). Click either name above to swap in a different company.

Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $6.1M, roughly 1.5× GSI TECHNOLOGY INC). GSI TECHNOLOGY INC runs the higher net margin — -49.7% vs -59.5%, a 9.8% gap on every dollar of revenue. On growth, GSI TECHNOLOGY INC posted the faster year-over-year revenue change (12.2% vs 0.9%). Cytosorbents Corp produced more free cash flow last quarter ($-4.9M vs $-8.2M). Over the past eight quarters, GSI TECHNOLOGY INC's revenue compounded faster (8.6% CAGR vs 1.3%).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.

CTSO vs GSIT — Head-to-Head

Bigger by revenue
CTSO
CTSO
1.5× larger
CTSO
$9.2M
$6.1M
GSIT
Growing faster (revenue YoY)
GSIT
GSIT
+11.3% gap
GSIT
12.2%
0.9%
CTSO
Higher net margin
GSIT
GSIT
9.8% more per $
GSIT
-49.7%
-59.5%
CTSO
More free cash flow
CTSO
CTSO
$3.2M more FCF
CTSO
$-4.9M
$-8.2M
GSIT
Faster 2-yr revenue CAGR
GSIT
GSIT
Annualised
GSIT
8.6%
1.3%
CTSO

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CTSO
CTSO
GSIT
GSIT
Revenue
$9.2M
$6.1M
Net Profit
$-5.5M
$-3.0M
Gross Margin
73.7%
52.7%
Operating Margin
-47.5%
-113.7%
Net Margin
-59.5%
-49.7%
Revenue YoY
0.9%
12.2%
Net Profit YoY
27.4%
25.0%
EPS (diluted)
$-0.09
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
GSIT
GSIT
Q4 25
$9.2M
$6.1M
Q3 25
$9.5M
$6.4M
Q2 25
$9.6M
$6.3M
Q1 25
$8.7M
$5.9M
Q4 24
$9.2M
$5.4M
Q3 24
$8.6M
$4.5M
Q2 24
$8.8M
$4.7M
Q1 24
$9.0M
$5.2M
Net Profit
CTSO
CTSO
GSIT
GSIT
Q4 25
$-5.5M
$-3.0M
Q3 25
$-3.2M
$-3.2M
Q2 25
$1.9M
$-2.2M
Q1 25
$-1.5M
$-2.2M
Q4 24
$-7.6M
$-4.0M
Q3 24
$-2.8M
$-5.5M
Q2 24
$-4.3M
$1.1M
Q1 24
$-6.1M
$-4.3M
Gross Margin
CTSO
CTSO
GSIT
GSIT
Q4 25
73.7%
52.7%
Q3 25
70.3%
54.8%
Q2 25
70.9%
58.1%
Q1 25
71.1%
56.1%
Q4 24
68.4%
54.0%
Q3 24
61.0%
38.6%
Q2 24
73.5%
46.3%
Q1 24
76.5%
51.6%
Operating Margin
CTSO
CTSO
GSIT
GSIT
Q4 25
-47.5%
-113.7%
Q3 25
-30.2%
-49.5%
Q2 25
-37.6%
-34.6%
Q1 25
-44.5%
-38.7%
Q4 24
-37.1%
-74.9%
Q3 24
-56.1%
-122.7%
Q2 24
-40.4%
23.1%
Q1 24
-51.8%
-87.6%
Net Margin
CTSO
CTSO
GSIT
GSIT
Q4 25
-59.5%
-49.7%
Q3 25
-33.4%
-49.4%
Q2 25
20.2%
-35.3%
Q1 25
-16.9%
-37.9%
Q4 24
-82.7%
-74.4%
Q3 24
-32.1%
-120.0%
Q2 24
-48.6%
23.1%
Q1 24
-67.7%
-83.9%
EPS (diluted)
CTSO
CTSO
GSIT
GSIT
Q4 25
$-0.09
$-0.09
Q3 25
$-0.05
$-0.11
Q2 25
$0.03
$-0.08
Q1 25
$-0.02
$-0.09
Q4 24
$-0.14
$-0.16
Q3 24
$-0.05
$-0.21
Q2 24
$-0.08
$0.04
Q1 24
$-0.11
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
GSIT
GSIT
Cash + ST InvestmentsLiquidity on hand
$6.2M
$70.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.9M
$83.6M
Total Assets
$44.2M
$98.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
GSIT
GSIT
Q4 25
$6.2M
$70.7M
Q3 25
$7.5M
$25.3M
Q2 25
$10.2M
$22.7M
Q1 25
$11.6M
$13.4M
Q4 24
$3.3M
$15.1M
Q3 24
$5.7M
$18.4M
Q2 24
$8.5M
$21.8M
Q1 24
$8.6M
$14.4M
Total Debt
CTSO
CTSO
GSIT
GSIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CTSO
CTSO
GSIT
GSIT
Q4 25
$5.9M
$83.6M
Q3 25
$9.0M
$38.6M
Q2 25
$11.6M
$37.4M
Q1 25
$14.5M
$28.2M
Q4 24
$11.1M
$29.9M
Q3 24
$13.4M
$33.3M
Q2 24
$17.4M
$38.0M
Q1 24
$19.6M
$36.0M
Total Assets
CTSO
CTSO
GSIT
GSIT
Q4 25
$44.2M
$98.5M
Q3 25
$45.8M
$52.0M
Q2 25
$48.0M
$50.5M
Q1 25
$50.8M
$43.3M
Q4 24
$47.4M
$44.1M
Q3 24
$47.8M
$47.4M
Q2 24
$53.4M
$52.3M
Q1 24
$47.1M
$42.5M
Debt / Equity
CTSO
CTSO
GSIT
GSIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
GSIT
GSIT
Operating Cash FlowLast quarter
$-4.8M
$-7.9M
Free Cash FlowOCF − Capex
$-4.9M
$-8.2M
FCF MarginFCF / Revenue
-53.4%
-134.4%
Capex IntensityCapex / Revenue
1.2%
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
GSIT
GSIT
Q4 25
$-4.8M
$-7.9M
Q3 25
$-2.6M
$-887.0K
Q2 25
$-1.5M
$-1.7M
Q1 25
$-3.5M
$-1.7M
Q4 24
$-2.3M
$-3.6M
Q3 24
$-2.5M
$-3.5M
Q2 24
$-4.8M
$-4.3M
Q1 24
$-4.8M
$-7.1M
Free Cash Flow
CTSO
CTSO
GSIT
GSIT
Q4 25
$-4.9M
$-8.2M
Q3 25
$-2.6M
$-906.0K
Q2 25
$-1.5M
$-1.7M
Q1 25
$-3.5M
$-1.7M
Q4 24
$-2.4M
$-3.6M
Q3 24
$-2.6M
$-3.5M
Q2 24
$-4.8M
$-4.3M
Q1 24
$-4.9M
$-7.2M
FCF Margin
CTSO
CTSO
GSIT
GSIT
Q4 25
-53.4%
-134.4%
Q3 25
-27.3%
-14.1%
Q2 25
-16.1%
-27.6%
Q1 25
-39.7%
-28.3%
Q4 24
-26.3%
-66.1%
Q3 24
-30.4%
-76.6%
Q2 24
-54.4%
-92.0%
Q1 24
-54.2%
-139.0%
Capex Intensity
CTSO
CTSO
GSIT
GSIT
Q4 25
1.2%
4.9%
Q3 25
0.2%
0.3%
Q2 25
0.4%
0.3%
Q1 25
0.0%
0.1%
Q4 24
0.8%
0.1%
Q3 24
1.8%
0.1%
Q2 24
0.2%
0.7%
Q1 24
0.5%
0.2%
Cash Conversion
CTSO
CTSO
GSIT
GSIT
Q4 25
Q3 25
Q2 25
-0.78×
Q1 25
Q4 24
Q3 24
Q2 24
-3.96×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

GSIT
GSIT

Distribution$5.6M92%
Other$459.0K8%

Related Comparisons